The Pharmacy Times® Pharmacy Technician Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to specialty pharmacists.
April 25th 2025
The Asembia AXS25 Summit will include the latest news and expert insights in the specialty pharmacy field.
Axium Healthcare Pharmacy Officially Releases OnePlace Patient Therapy Management Web Portal
July 18th 2012Axium Healthcare Pharmacy, one of the nation's largest independent specialty pharmacy providers, announced the official release of its highly-anticipated OnePlace patient therapy management web portal.
Read More
Pharma Companies to Receive Incentives to Address Unmet Pediatric Medical Need
July 17th 2012Legislation by representatives Michael McCaul (R, TX) and G.K. Butterfield (D, NC), offering drug companies millions of dollars in incentives to develop treatments for rare pediatric disease, was recently signed by the president.
Read More
FDA Approves First DNA Test to Help Manage CMV Infection in Organ Transplant Patients
July 9th 2012The FDA recently approved the first DNA test to help health care professionals gauge the progress of antiviral treatment in solid organ transplant patients undergoing cytomegalovirus (CMV) antiviral therapy.
Read More
From The American Journal of Managed Care, "On the Horizon for Multiple Myeloma"
July 5th 2012This article-written by Michael Marlan Mohundro, PharmD; and Brice Labruzzo Mohundro, PharmD-highlights the multiple available regimens for patients with relapsed or refractory myelomas as well as new treatments that are currently being investigated in clinical trials.
Read More
Collaborative Cancer Care: Express Scripts and the National Comprehensive Cancer Network
July 5th 2012Specialty Pharmacy Times spoke to Milayna Subar, MD, vice president and national practice leader in oncology for the Oncology Therapeutic Resource Center (TRC) at Express Scripts, to learn more about how access to clinical practice guidelines in oncology can help shape the complex landscape of cancer treatment.
Read More
Adult patients with refractory chronic gout (RCG) treated bi-weekly with Krystexxa (pegloticase) experienced statistically significant and clinically meaningful improvements in health-related quality of life (HRQOL), pain, and physical function, according to an analysis in The Journal of Rheumatology.
Read More
The Leukemia & Lymphoma Society and Celator Pharmaceuticals Announce $5 Million Partnership
July 3rd 2012The Leukemia & Lymphoma Society (LLS) and Celator Pharmaceuticals, Inc announced a significant expansion of their partnership to support clinical development of Celator's CPX-351 (cytarabine:daunorubicin) liposome injection for treatment of adults with acute myeloid leukemia (AML).
Read More
Managed Health Care Associates, Inc Launches BizMed Program to Alternate Site Health Care Providers
June 29th 2012MHA's BizMed Program was created to offer MHA members a comprehensive portfolio of medical products, services and innovative business solutions to help them achieve operational efficiency while controlling bottom line performance.
Read More
Data on Investigational Oral Octreolin for Acromegaly Demonstrate Growth Hormone Suppression
June 28th 2012Chiasma recently presented data at the annual meeting of The Endocrine Society that show Octreolin (oral octreotide) reduced pituitary growth hormone secretion in healthy volunteers as effectively as shown in published studies of injectable octreotide.
Read More
Speaker Lineup Released for Pharmacy Benefits Academy; Managing Specialty Pharmacy Key Focus
June 25th 2012The Midwest Business Group on Health in collaboration with Pharmacy Outcomes Specialists announced the keynote speakers and agenda for the sixth annual Pharmacy Benefits Academy (PBA) to be held July 31-August 1 at the Westin O'Hare.
Read More
Genzyme Seeks Approval for Multiple Sclerosis Drug Lemtrada
June 20th 2012Sanofi's Genzyme unit announced in a press release earlier last week that the company has submitted an application to regulatory authorities for approval of Lemtrada (alemtuzumab) for the treatment of relapsing multiple sclerosis (RMS).
Read More
Alzheimer's Association Launches "The Longest Day" Event
June 18th 2012On June 20th, 2012, the longest day of the year, the Alzheimer's Association is asking participants to run, walk, bike, or engage in some kind of endurance activity for 16 consecutive hours to honor those facing Alzheimer's disease.
Read More
SXC Health Solutions Receives URAC Specialty Pharmacy Accreditation
June 18th 2012SXC Health Solutions Corp announced that it has been awarded Specialty Pharmacy Accreditation from URAC, a Washington, DC-based health care accrediting organization that establishes quality standards for the health care industry.
Read More
Phase 3 study findings showed that patients with active moderate to severe rheumatoid arthritis (RA) who received an investigational intravenous (IV) formulation of the anti-tumor necrosis factor (TNF)-alpha therapy Simponi (golimumab) demonstrated significant improvements in signs, symptoms, and disease activity.
Read More
Argus Expands Specialty Pharmacy with Amber Pharmacy Collaboration
June 13th 2012Argus Health Systems, Inc, a leading transparent pharmacy benefits administrator, recently announced that it has established a Preferred Specialty Program with Amber Pharmacy to provide expanded network options.
Read More